191 related articles for article (PubMed ID: 8601421)
21. Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal beta-oxidation in primary cultures of rainbow trout hepatocytes.
Donohue M; Baldwin LA; Leonard DA; Kostecki PT; Calabrese EJ
Ecotoxicol Environ Saf; 1993 Oct; 26(2):127-32. PubMed ID: 7504609
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
Richert L; Price S; Chesne C; Maita K; Carmichael N
Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
[TBL] [Abstract][Full Text] [Related]
23. Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.
Herbert JM; Bernat A; Chatenet-Duchène L
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):239-44. PubMed ID: 10456614
[TBL] [Abstract][Full Text] [Related]
24. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
[TBL] [Abstract][Full Text] [Related]
25. Maturation of peroxisomes in differentiating human hepatoblastoma cells (HepG2): possible involvement of the peroxisome proliferator-activated receptor alpha (PPAR alpha).
Stier H; Fahimi HD; Van Veldhoven PP; Mannaerts GP; Völkl A; Baumgart E
Differentiation; 1998 Nov; 64(1):55-66. PubMed ID: 9921653
[TBL] [Abstract][Full Text] [Related]
26. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
Lee MJ; Gee P; Beard SE
Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric assessment of peroxisome proliferation from frozen liver of fibrate-treated monkeys.
Kwanyuen P; Witherspoon SM; Creech DR; Colton HM; Falls JG; Cariello NF
Int J Toxicol; 2006; 25(1):41-7. PubMed ID: 16510356
[TBL] [Abstract][Full Text] [Related]
28. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
29. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
30. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
31. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.
Zangar RC; Woodcroft KJ; Novak RF
Toxicol Appl Pharmacol; 1996 Nov; 141(1):110-6. PubMed ID: 8917682
[TBL] [Abstract][Full Text] [Related]
33. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
Leung LK; Glauert HP
Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
[TBL] [Abstract][Full Text] [Related]
34. Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.
Hoivik DJ; Qualls CW; Mirabile RC; Cariello NF; Kimbrough CL; Colton HM; Anderson SP; Santostefano MJ; Morgan RJ; Dahl RR; Brown AR; Zhao Z; Mudd PN; Oliver WB; Brown HR; Miller RT
Carcinogenesis; 2004 Sep; 25(9):1757-69. PubMed ID: 15131011
[TBL] [Abstract][Full Text] [Related]
35. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
36. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
37. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
38. Administration of ciprofibrate to lactating mothers induces PPARalpha-signaling pathway in the liver and kidney of suckling rats.
Fidaleo M; Sartori C
Exp Toxicol Pathol; 2008 Jun; 60(1):33-41. PubMed ID: 18434116
[TBL] [Abstract][Full Text] [Related]
39. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
Hong JT; Wilson MW; Glauert HP
J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
[TBL] [Abstract][Full Text] [Related]
40. [Effects of Ganoderma lucidum spores on HepG2 cells proliferation and growth cycle].
Li L; Li T; Wang XJ; Xu JP; Wang SG
Zhong Yao Cai; 2008 Oct; 31(10):1514-8. PubMed ID: 19230404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
